Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

Viatris

Status and phase: Completed; Phase 3

Conditions: Anxiety

Treatments: Drug: Venlafaxine XR; Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00151450

A0081012

Details and patient eligibility

About

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female outpatients with diagnosis of generalized anxiety disorder.

Exclusion criteria

• Any serious or uncontrolled medical condition.
• Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind